ASX:COHMedical Equipment
Cochlear (ASX:COH) Is Down 9.1% After FDA Clearance For Osia 3 Sound Processor - Has The Bull Case Changed?
Cochlear Limited recently received FDA clearance for its Osia 3 Sound Processor, a fully rechargeable active bone conduction device offering up to 30 hours of battery life, broader fitting range, enhanced sound processing and extensive wireless connectivity features for people with conductive or mixed hearing loss and single-sided deafness.
An interesting angle for investors is the Osia 3’s backwards compatibility and Remote Care support, which could encourage upgrades from the existing...
